RepaglinideRepaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes. Read from the Drugbox of the Wikipedia article Repaglinide, revision 1379956534.

Property

Value

Formula

C27H36N2O4, 452.59 g/mol

Melting point

127 °C

Bioavailability

56 %

Protein binding

98 %

Elimination half-life

1 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.